New Drug for Moderate-to-Severe Plaque Psoriasis Approved in Record Time

The FDA today approved ICOTYDE (icotrokinra), the first oral pill that targets the IL-23 pathway for moderate-to-severe plaque psoriasis, marking a...

The FDA today approved ICOTYDE (icotrokinra), the first oral pill that targets the IL-23 pathway for moderate-to-severe plaque psoriasis, marking a...

Two FDA-approved intranasal sprays — Nayzilam (midazolam) and Valtoco (diazepam) — are fundamentally changing how seizure clusters are managed outside of...

Some antifungal drugs require monthly liver monitoring because they are metabolized through the liver's cytochrome P450 enzyme system, and that metabolic...

After decades with no targeted treatments, patients with systemic mastocytosis finally have real pharmaceutical options — and the pipeline is still...

A class of drugs originally designed to lower blood sugar in people with type 2 diabetes has crossed into entirely new territory — and the implications...

In December 2025, the FDA approved two new oral antibiotics for gonorrhea — the first new treatments for the infection in nearly two decades.

Patients are being warned about buying medication from online pharmacies because the vast majority of these websites are illegal operations that sell...

In August 2025, the FDA approved the first-ever generic GLP-1 receptor agonist specifically indicated for weight loss — Teva Pharmaceuticals' generic...

On March 10, 2026, the FDA approved Wellcovorin (leucovorin calcium) tablets as the first-ever treatment for cerebral folate transport deficiency caused...

The answer is deceptively simple: your asthma inhaler could contain the most effective medication on the market, but if you cannot operate the device...
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.